Ixchiq: World’s First Chikungunya Vaccine Approved By FDA | Vaccine For Chikungunya | US News

This single-dose vaccine is intended for individuals aged 18 and older at a heightened risk of Chikungunya virus exposure, transmitted primarily through infected mosquitoes.

Hyderabad: The US Food and Drug Administration (FDA) has granted approval for Ixchiq, the world’s first chikungunya vaccine developed by French biotech company Valneva.

This single-dose vaccine is intended for individuals aged 18 and older at a heightened risk of Chikungunya virus exposure, transmitted primarily through infected mosquitoes.

---